Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
4th March 2026 Uncategorised 0
New funding will support the phase 2 expansion trial of THEO-260

More: Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
Source: News
